Researchers Begin Merging Bio-, Cheminformatics In Race Down the Drug Discovery Superhighway | GenomeWeb

FOR YEARS bioinformaticists and cheminformaticists inhabited distinct realms of the scientific universe. But over the past year, a handful of companies have announced mergers, acquisitions, and partnerships that indicate that the walls separating the two disciplines are coming down.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.